(Q54528429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Zsolt Sarszegi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Eszter Bognar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Balazs Gaszner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Attila Kónyi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Balazs Sumegi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Zoltan Berente

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

14 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

129-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11010-012-1252-8

23 January 2020

exact match

0 references

cites work

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

BNP as a marker of the heart failure in the treatment of imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Cardiotoxicity induced by tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Cardioprotective effects of poly(ADP-ribose) polymerase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

STRESS signaling pathways that modulate cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Akt activation induced by an antioxidant compound during ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

The role of Ca(2+) signaling in the coordination of mitochondrial ATP production with cardiac work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Oxidative stress and left ventricular remodelling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1252-8

Salvage of ischemic myocardium: a focus on JNK.

21 January 2018

1 reference

12 December 2020

Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.

1 reference

12 December 2020

Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases

1 reference

12 December 2020

Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.

1 reference

12 December 2020

BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase

1 reference

12 December 2020

Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity

1 reference

12 December 2020

Lipid peroxidation activation and cytochrome P-450 decrease in rat liver endoplasmic reticulum under oxidative stress

1 reference

12 December 2020

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

1 reference

12 December 2020

10.1007/S11010-012-1252-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350755%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference